Back

Immune-oncology-microbiome axis may result in AKP or anti-AKP effects in intratumor microbiomes

2024-03-26 oncology Title + abstract only
View on medRxiv
Show abstract

An emerging consensus regarding the triangle relationship between tumor, immune cells, and microbiomes is the immune-oncology-microbiome (IOM) axis, which stipulates that microbiomes can act as a discrete enabling (or disabling) characteristic that broadly influence the acquisition of certain hallmarks of cancer, i.e., a set of functional capabilities acquired by human cells during carcinogenesis and progression to malignant tumors. Specifically, it has been postulated that polymorphic microbiom...

Predicted journal destinations